Results 311 to 316 of about 53,199 (316)

Molecular orbital studies on the mechanism of drug-receptor interaction. 5. Molecular reactivity and receptor affinity of beta-agonist adrenergic drugs.

Drug design and delivery, 1989
The electrostatic molecular potential (EMP) of model compounds (isoproterenol and four of its analogs) with agonist activity on the beta-adrenergic receptor was investigated, at the SCF-MO ab initio level. A method was developed to calculate the drug-receptor interaction energy (delta E) for these compounds, and the EMP and delta E values were compared
B, Macchia, A, Martinelli
openaire   +1 more source

Dual Treatment of a Beta 3 Adrenergic Receptor Agonist and a Novel Estrogen Receptor Beta Agonist on Body Composition, Metabolism, and Glucose Tolerance in Obese Male Mice

Physiology
INTRODUCTION: Estrogen is protective against weight gain via mechanisms mediated by adipocyte-specific receptors. Specifically, estrogen receptor beta (ERb) activation is non-feminizing and increases adipocyte mitochondrial activity leading to increased energy expenditure (EE ...
John Cullen, Dusti Shay, Kayla Burkle, Trinity Cunningham, Samantha Marquis, Samuel Kulp, Christopher Coss, Victoria Vieira-Potter   +7 more
openaire   +1 more source

Potentiation by beta agonists of alpha adrenergically mediated contractions in the guinea-pig vas deferens

European Journal of Pharmacology, 1990
M.A. Khayyal, T.T. Abdel-Razek, A.Y. Awad, H.M. Sharaf   +3 more
openaire   +1 more source

Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.

BJOG : an international journal of obstetrics and gynaecology, 2001
To compare the effectiveness and safety of the oxytocin antagonist atosiban with conventional beta-adrenergic agonist (beta-agonist) therapy in the treatment of preterm labour.Three multinational, multicentre, double-blind, randomised, controlled trials. Setting Hospitals in Australia, Canada, Czech Republic, Denmark, France, Israel, Sweden, and the UK.
openaire   +1 more source

Effects Of Rare ²2-Adrenergic Receptor Gene Variants And Long-Acting Beta Agonists On Healthcare Utilization And Corticosteroid Use In Two Multi-Ethnic Asthma Populations

B21. GENETICS OF ASTHMA, 2012
Victor E. Ortega, Gregory Hawkins, Annette T. Hastie, Wendy C. Moore, Alireza Sadeghnejad, William W. Busse, Serpil C. Erzurum, Sally E. Wenzel, Stephen P. Peters, Deborah A. Meyers, Eugene R. Bleecker   +10 more
openaire   +1 more source

[Adrenergic beta agonists (adrenaline, dopamine, dobutamine, salbutamol); beta-blockers. Fundamentals and rules of use].

La Revue du praticien, 1998
openaire   +1 more source